Related Experiment Video
Updated: Jan 6, 2026

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression
Han Zhang1, Pengtao Wei1, Wenwei Lv1
1Urology Department, Luoyang Central Hospital, No. 288, Zhongzhou Road, Luoyang, 471000 Henan China.
Background:
Increasing evidence has indicated that long noncoding RNAs (lncRNAs) are crucial regulators affecting the progression of human cancers. Recently, lncRNA downregulated in liver cancer stem cells (lnc-DILC) was identified to function as a tumor suppressor inhibiting the tumorigenesis and metastasis in liver cancer and colorectal cancer. However, to date, little is known about the functional roles of lnc-DILC in modulating malignant phenotypes of clear cell renal cell carcinoma (ccRCC) cells.
Methods:
lnc-DILC expression in human ccRCC tissues was detected by qRT-PCR. Overexpression and knockdown experiments were carried out to determine the effects of lnc-DILC on ccRCC cell proliferation, migration and invasion. To reveal the underlying mechanisms of lnc-DILC functions in ccRCC cells. RNA immunoprecipitation, RNA pull-down, in vivo ubiquitination, co-immunoprecipitation and western blot assays were performed.
Results:
Here, we identified that lnc-DILC levels were dramatically downregulated in ccRCC tissues. Loss of lnc-DILC expression was correlated with larger tumor size, advanced tumor grade and lymph node metastasis, and also predicted worse prognosis in patients with ccRCC. Functionally, knockdown and overexpression experiments demonstrated that lnc-DILC inhibited cell proliferation, migration and invasion in ccRCC cells. Mechanistic investigation revealed that lnc-DILC bound to tumor suppressor PTEN and suppressed its degradation. lnc-DILC repressed the PTEN ubiquitination through blocking the interaction between PTEN and E3 ubiquitin ligase WWP2 and recruiting the deubiquitinase USP11 to PTEN. Moreover, we demonstrated that PTEN-AKT signaling was crucial for lnc-DILC-mediated suppressive effects.
Conclusions:
In summary, our research revealed a novel mechanism by which lnc-DILC regulates PTEN stability via WWP2 and USP11, and shed light on potential therapeutic strategies by the restoration of lnc-DILC expression in patients with ccRCC.
Insights
Long noncoding RNA DILC (lnc-DILC) acts as a tumor suppressor in clear cell renal cell carcinoma (ccRCC). Restoring lnc-DILC inhibits ccRCC progression by stabilizing PTEN, offering potential therapeutic strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long noncoding RNAs (lncRNAs) are implicated in human cancer progression.
- lncRNA downregulated in liver cancer stem cells (lnc-DILC) acts as a tumor suppressor in liver and colorectal cancers.
- The role of lnc-DILC in clear cell renal cell carcinoma (ccRCC) remains largely unknown.
Purpose of the Study:
- To investigate the functional role of lnc-DILC in ccRCC.
- To elucidate the underlying molecular mechanisms of lnc-DILC in ccRCC.
- To assess the potential of lnc-DILC as a therapeutic target for ccRCC.
Main Methods:
- Quantitative real-time PCR (qRT-PCR) to detect lnc-DILC expression in ccRCC tissues.
- Overexpression and knockdown experiments to assess ccRCC cell proliferation, migration, and invasion.
- RNA immunoprecipitation, RNA pull-down, ubiquitination, co-immunoprecipitation, and western blot assays to determine molecular mechanisms.
Main Results:
- lnc-DILC expression is significantly downregulated in ccRCC tissues and correlates with advanced tumor features and poor prognosis.
- lnc-DILC suppresses ccRCC cell proliferation, migration, and invasion.
- lnc-DILC stabilizes the tumor suppressor PTEN by inhibiting its ubiquitination and degradation via interactions with WWP2 and USP11, impacting PTEN-AKT signaling.
Conclusions:
- lnc-DILC functions as a tumor suppressor in ccRCC by regulating PTEN stability.
- A novel mechanism involving lnc-DILC, PTEN, WWP2, and USP11 in ccRCC progression is revealed.
- Restoration of lnc-DILC expression represents a potential therapeutic strategy for ccRCC patients.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
Abnormal Proliferation
Non-LTR Retrotransposons
piRNA - Piwi-interacting RNAs
MicroRNAs